[EN] NEW BENZIMIDAZOLE PYRIDINE DERIVATIVES<br/>[FR] NOUVEAUX DÉRIVES DE BENZIMIDAZOLE PYRIDINE
申请人:[en]F. HOFFMANN-LA ROCHE AG
公开号:WO2023139085A1
公开(公告)日:2023-07-27
The invention relates to a compound of formula (I) wherein A1, A2, A3, R1, R2, R2', R3, R4and R5are as defined in the description and in the claims. The compound of formula (I) can be used as a medicament.
[EN] IMIDAZO[4,5-B]PYRIDINE AND PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES AS SIK MODULATORS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS<br/>[FR] DÉRIVÉS D'IMIDAZO[4,5-B]PYRIDINE ET DE PYRAZOLO[1,5-A]PYRIMIDINE UTILISÉS EN TANT QUE MODULATEURS DE SIK POUR LE TRAITEMENT DE LA POLYARTHRITE RHUMATOÏDE
申请人:[en]F. HOFFMANN-LA ROCHE AG
公开号:WO2024003208A1
公开(公告)日:2024-01-04
The invention relates to a compound of formula (I) as SIK modulators for the treatment or prophylaxis of rheumatoid arthritis, juvenile rheumatoid arthritis, non-alcoholic steatohepatitis (NASH), primary sclerosing cholangitis, giant cell vasculitis, inflammatory bowel diseases (IBD), atherosclerosis, type 2 diabetes or glomerulonephritis. Preferred compounds are e.g. imidazo[4,5-b]pyridine derivatives or pyrazolo[1,5-a]pyrimidine derivatives.